Karyopharm Therapeutics Inc. (KPTI): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$974.0K
Year ended 2019-12-31
+10.8%
3-year compound annual growth
+24.7%
5-year compound annual growth
2011-12-31: $83.0K2012-12-31: $122.0K2013-12-31: $144.0K2014-12-31: $323.0K2015-12-31: $634.0K2016-12-31: $717.0K2017-12-31: $713.0K2018-12-31: $735.0K2019-12-31: $974.0K$974.0K
2011-12-31 Depreciation & Amortization (USD) 2019-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2019-12-31$974.0K+32.5%2020-02-26, From 2019-01-01
2018-12-31$735.0K+3.1%2020-02-26, From 2018-01-01
2017-12-31$713.0K-0.6%2020-02-26, From 2017-01-01
2016-12-31$717.0K+13.1%2019-02-28, From 2016-01-01
2015-12-31$634.0K+96.3%2018-03-15, From 2015-01-01
2014-12-31$323.0K+124.3%2017-03-16, From 2014-01-01
2013-12-31$144.0K+18.0%2016-03-15, From 2013-01-01
2012-12-31$122.0K+47.0%2015-03-13, From 2012-01-01
2011-12-31$83.0Kn/a2014-03-21, From 2011-01-01